AA
CTMX icon

ALPS Advisors’s CytomX Therapeutics CTMX Stock Holding History

ALPS Advisors’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Buy
+105,820
New +$537K ﹤0.01% 835
2022
Q2 		– Sell
-67,211
Closed -$179K – 1046
2022
Q1 		$179K Sell
67,211
-8,302
-11% -$31.9K ﹤0.01% 809
2021
Q4 		$327K Sell
75,513
-4,340
-5% -$25.4K ﹤0.01% 811
2021
Q3 		$406K Sell
79,853
-5,776
-7% -$30.9K ﹤0.01% 538
2021
Q2 		$542K Buy
85,629
+2,000
+2% +$15.6K ﹤0.01% 506
2021
Q1 		$646K Buy
83,629
+136
+0.2% +$1.08K 0.01% 463
2020
Q4 		$547K Buy
+83,493
New +$596K 0.01% 482
2020
Q2 		– Sell
-82,601
Closed -$634K – 791
2020
Q1 		$634K Sell
82,601
-9,632
-10% -$67.2K 0.01% 402
2019
Q4 		$766K Buy
+92,233
New +$622K 0.01% 423

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return